Viewing Study NCT00160160


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-04-29 @ 11:17 PM
Study NCT ID: NCT00160160
Status: COMPLETED
Last Update Posted: 2009-01-30
First Post: 2005-09-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
Sponsor: Solvay Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
None Type 2 Diabetes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None comparator trial View
None hypertension View
None diabetes View
None blood pressure View